Yasunobu Nosaki Ken Ohyama Maki Watanabe Takamasa Yokoi Kazuo Nakamichi Masayuki Saijo Yoshiharu Miura Katsushige Iwai
10.2169/internalmedicine.2570-18
Intern Med
2019;58(18):2703-2709.
jc virus cryptococcal meningitis infliximab methotrexate progressive multifocal leukoencephalopathy
CC BY-NC-ND
https://pubmed.ncbi.nlm.nih.gov/31527369/
Antifungal Agents / therapeutic use Antirheumatic Agents / adverse effects Arthritis, Rheumatoid / drug therapy Immunosuppression Therapy / adverse effects Infliximab / adverse effects Leukoencephalopathy, Progressive Multifocal / drug therapy Meningitis, Cryptococcal / drug therapy Methotrexate / adverse effects
Antifungal Agents / therapeutic use Antirheumatic Agents / adverse effects Arthritis, Rheumatoid / drug therapy Immunosuppression Therapy / adverse effects Infliximab / adverse effects Leukoencephalopathy, Progressive Multifocal / drug therapy Meningitis, Cryptococcal / drug therapy Methotrexate / adverse effects Case Reports Aged Antirheumatic Agents / therapeutic use Female Humans Infliximab / therapeutic use JC Virus / isolation & purification Leukoencephalopathy, Progressive Multifocal / etiology Meningitis, Cryptococcal / etiology Methotrexate / therapeutic use Treatment Outcome Antifungal Agents Antirheumatic Agents Infliximab Methotrexate
PMC6794173
31527369
Simultaneous Development of Progressive Multifocal Leukoencephalopathy and Cryptococcal Meningitis during Methotrexate and Infliximab Treatment
2019